Novo Nordisk Pharma AG - Tresiba Penfill, Injektionslösung |
| 62562 | | 01 | | Tresiba Penfill | | Injektionslösung | | A10AE06 | | Insulin Degludec | | 12.03.2013 | | |
|
Composition |
insulinum degludecum 600 nmol corresp. insulinum degludecum 100 U., glycerolum, zincum ut zinci acetas dihydricus, phenolum, metacresolum 1.72 mg, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
Packungsbestandteile |
| Injection solution | | | | | | Active Agent | Dose |
---|
Insulinum Degludecum | 600 | Nmol | |
| BAG: Active Agent | Dose |
---|
Insulinum Degludecum | 100 U |
| | Inactive agents | Dose |
---|
Acidum Hydrochloridum ad Ph | | Glycerol | | Metacresol | 1.72 mg/ml | Natrii Hydroxidum ad Ph | | Phenol | | Zincum | |
| |
|
Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | 5 x 3 ml | 81.59 | 105.15 | B | SL | Yes |
|